|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.40 PLN | +1.47% |
|
+1.30% | -8.66% |
| 27/05 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| 15/05 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
Company Valuation: Scope Fluidics S.A.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| Market Cap 1 | 447.1 | 394.1 | 394.1 | - |
| Change | - | -11.84% | 0% | - |
| Enterprise Value (EV) 1 | 447.1 | 287.1 | 297 | -100.1 |
| Change | - | -35.77% | 3.45% | -133.69% |
| P/E Ratio | 6.83x | -9.3x | -7.23x | 0.98x |
| PBR | - | 3.17x | 3.65x | 0.78x |
| PEG | - | 0x | -0.4x | -0x |
| Capitalization / Revenue | - | 4,315x | 158x | - |
| EV / Revenue | - | 410x | 119x | - |
| EV / EBITDA | - | -7.68x | -4.55x | 1.23x |
| EV / EBIT | - | -7.32x | -4.33x | 1.18x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | 24 | -14.64 | -17.2 | 126.4 |
| Distribution rate | - | - | - | - |
| Net sales 1 | - | 0.1 | 2.5 | - |
| EBITDA 1 | - | -37.4 | -65.3 | -81.1 |
| EBIT 1 | - | -47.28 | -68.6 | -84.6 |
| Net income 1 | 65.42 | -46.36 | -54.4 | 400.5 |
| Net Debt 1 | - | -107 | -97.1 | -494.2 |
| Reference price 2 | 164.00 | 124.40 | 124.40 | 124.40 |
| Nbr of stocks (in thousands) | 2,726 | 3,168 | 3,168 | - |
| Announcement Date | 28/04/25 | 25/03/26 | - | - |
1PLN in Million2PLN
Estimates
P/E Ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| -8.64x | 410.19x | -7.68x | - | 11Cr | ||
| 43.77x | 5.53x | 20.74x | -.--% | 377.66Cr | ||
| -38.14x | 9.4x | -3791.31x | -.--% | 281.68Cr | ||
| -7.48x | 4.46x | -7.01x | -.--% | 182.17Cr | ||
| 3062.67x | - | - | - | 118.66Cr | ||
| 15.9x | 1.75x | 6.37x | 3.92% | 85Cr | ||
| -16.06x | 3.55x | 24.33x | -.--% | 73Cr | ||
| Average | 436.00x | 72.48x | -625.76x | 0.78% | 161.39Cr | |
| Weighted average by Cap. | 325.68x | 10.26x | -1,047.54x | 0.33% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SCP Stock
- Valuation Scope Fluidics S.A.
Select your edition
All financial news and data tailored to specific country editions
















